ResMed (RMD) Stock: Buy, Sell, or Hold?
$234.11
-1.63 (-0.69%)
âŧ
5d:
+3.1%
30d:
-0.21%
90d:
+3.59%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (49%)
Quality Score
52/100
Position
FAIR
30-Day Fair Range
$224.47 â $246.73
Position: FAIR
Forward P/E & Valuation
19.4x
FAIR
vs 19.1x historical avg
Wall Street Target
$264.33
+12.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$221.59 / $254.27
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: RMD is fairly priced but lacks strong directional signals. At 0.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When RMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$313.04
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$194.38
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RMD is currently trading at $234.11, which is considered fair relative to its 30-day fair value range of $224.47 to $246.73. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (19.1). At these levels, the market is pricing in 0.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RMD is in a strong uptrend. Immediate support is located at $221.59, while resistance sits at $254.27.
Market Sentiment: RMD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $264.33 (+12.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RMD is in a strong uptrend. Immediate support is located at $221.59, while resistance sits at $254.27.
Market Sentiment: RMD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $264.33 (+12.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$224.47 -
$246.73
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Trading Range & Key Levels
30-Day Trading Range
$224.47 -
$246.73
Current vs Trading Range
FAIR
Support Level
$221.59
Resistance Level
$254.27
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding RMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($264.33)
- NEUTRAL: Market pricing in 0.4% annual earnings growth - fairly valued
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
19.38
Wall Street Target
$264.33
(+12.9%)
Revenue Growth (YoY)
5.9%
Earnings Growth (YoY)
23.2%
Profit Margin
27.8%
Valuation Premium vs History
+0.4% premium
PE vs Historical
19.4 vs 19.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$235.05
(+0%)
2-Year Target
$235.99
(+1%)
3-Year Target
$236.93
(+1%)
3-Yr Target (if PE normalizes)
(PE: 19â19)
PE COMPRESSION
$233.56
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 8.6%)
$307.57
(+31%)
Base:
(SPY PE: 19.4, Growth: 8.6%)
$300.07
(+28%)
Bear:
(PE: 16.5, Growth: 8.6%)
$255.06
(+9%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 21.47 | Current EPS (TTM): $10.98
Bull Case
$285.35
(+22%)
Analyst growth 10.0%, PE expands to 23.6
Base Case
$259.41
(+11%)
Market implied 10.0%, PE stable at 21.5
Bear Case
$160.30
(-32%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share RMD Analysis
Share this live RMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RMD)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate overwhelmingly bullish sentiment towards $RMD with a 100.0% bullish score. Traders are optimistic about the company's recent earnings beat and view Resmed as extremely undervalued.
Key Retail Themes:
earnings beat
undervaluation
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 8:58 PM ET
Data refreshes hourly during market hours. Next update: 9:58 PM
Data refreshes hourly during market hours. Next update: 9:58 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 39 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 27 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
16 analysts |
$471 | 52 HOLD |
|
KMTS
Kestra Medical TechnologâĻ |
STRONG BUY
9 analysts |
$31 | 55 HOLD |
Advanced RMD Option Strategies
Professional options setups generated by AI based on today's RMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RMD Research Pages
